These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Multiresistant Enterobacteriaceae: new threat of an old problem. Pitout JD Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404 [TBL] [Abstract][Full Text] [Related]
9. [Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control]. Dolapçi I Mikrobiyol Bul; 2005 Apr; 39(2):229-40. PubMed ID: 16128036 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of extended-spectrum beta-lactamases. Rodríguez-Baño J; Pascual A Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405 [TBL] [Abstract][Full Text] [Related]
11. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents. Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden. Ostholm-Balkhed A; Tärnberg M; Nilsson M; Johansson AV; Hanberger H; Monstein HJ; Nilsson LE Scand J Infect Dis; 2010 Dec; 42(11-12):831-8. PubMed ID: 20608768 [TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamase-type SHV-12-producing Enterobacteriaceae causing septicemia in Tanzanian children: vectors for horizontal transfer of antimicrobial resistance. Tellevik MG; Sollid JE; Blomberg B; Jureen R; Urassa WK; Langeland N Diagn Microbiol Infect Dis; 2007 Nov; 59(3):351-4. PubMed ID: 17878065 [TBL] [Abstract][Full Text] [Related]
14. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists. Colodner R Am J Infect Control; 2005 Mar; 33(2):104-7. PubMed ID: 15761410 [TBL] [Abstract][Full Text] [Related]
15. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases. Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568 [TBL] [Abstract][Full Text] [Related]
16. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Pfaller MA; Segreti J Clin Infect Dis; 2006 Apr; 42 Suppl 4():S153-63. PubMed ID: 16544266 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae. Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae. Ku YH; Chuang YC; Yu WL J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741 [TBL] [Abstract][Full Text] [Related]
19. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India. Behera B; Mathur P; Das A; Kapil A Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]